(R)-2-((tert-Butoxycarbonyl)amino)-3-(4-(tert-butyl)phenyl)propanoic acid, 95.0%, 1g

Essigsäure-n-butylester, min. 99 %, zur Synthese, 10 l, Weißbl.

1-(4-Chlorophenyl)-2-methylpropan-1-amine hydrochloride, 95.0%, 250mg

2-chloro-N-(3-cyano-2-thienyl)acetamide, 95.0%, 250mg

Methyl 5-chloropentanoate, 95.0%, 25g

{[(4-chlorophenyl)methyl]sulfanyl}methanimidamide hydrobromide, 95.0%, 1g

2-(Benzo[b]thiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

2-Ethynyl-3-fluoropyridine, 97%, 25g

(1R,3R)-5-Bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione, 97%, 1g

4-Bromo-5-iodo-6-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 250mg

Quinuclidin-3-yl acetate, 95.0%, 100g

dCTP-Lösung

4-(Piperidin-3-yl)morpholine dihydrochloride, 98%, 250mg